相关人员
Dr. Anja Lunze, LL.M.
Anja heads our Life Sciences & Healthcare group in Germany. She is a specialist lawyer for intellectual property law and has been working in the area of patent law for over 15 years. Anja manages and coordinates complex, multinational patent infringement proceedings and drafts infringement and nullity opinions.
She advises on parallel opposition and nullity proceedings before the European Patent Office, the Federal Patent Court and the Federal Supreme Court. In particular, Anja represents clients from the fields of pharmaceuticals, biotech, personalised medicine and precision medicine as well as from the chemical and medical device industries and advises on related issues of digitisation. Having spent time in Geneva, Strasbourg, Tokyo and London, Anja has intercultural competence and language skills (including English, French and Japanese).
显示完整简历
隐藏完整简历
更多
更少
更多
更少
职业发展
| 2019 | Mentorin women, IP e.V. |
| Since 2011 | Lawyer, Taylor Wessing |
| Since 2011 | Lecturer, Munich Business School |
| 2011 – 2014 | Lecturer, Technische Universität Dresden |
| Since 2011 | Lawyer, Taylor Wessing |
| 2006 – 2011 | Lawyer, Düsseldorf patent litigation firm |
教育
| 2009 | Specialist lawyer for Industrial Property Law |
| 2006 | Doctoral degree, summa cum laude, Ph.D. thesis on the "Legal consequences of patent invalidity. Analysis of German, French and U.S. American Law”, which was awarded the Faculty of Law Doctoral Prize at the Technical University of Dresden in 2007, Technical University Dresden |
| 2006 | Admitted as a lawyer, Düsseldorf |
| 2005 | Second state examination, Düsseldorf |
| 2003 – 2005 | Legal trainee solicitor, large international and large national law firm, Düsseldorf, Hamburg and Tokyo |
| 2001 – 2003 | Doctoral scholarship for doctorate studies, Technical University Dresden |
| 2000 – 2001 | LL.M., International Studies in Intellectual Property Law, Centre d’Etudes Internationales de la Propriété Intellectuelle (CEIPI) Strasbourg and the Technical University Dresden |
| 2000 | First state examination, Heidelberg |
| 1995 – 2000 | Legal studies, Technical University Dresden, University of Geneva and University of Heidelberg |
Publications
Einschränkungen der Patentinhaber im Bereich versorgungsrelevanter Produkte: Im Gespräch über Patentschutz für Corona-Impfstoff mit SWR2, 02/2021 Prozesskommentar Gewerblicher Rechtsschutz, in: 2. Auflage C.H. Beck, 2018, §§ 704 - 857 ZPO Rechtsfolgen des Fortfalls des Patents, in: Nomos, 2007 Kommentar Gewerblicher Rechtsschutz, in: 3. Auflage Heymanns 2018, §§ 16, S. 20 - 23, S. 70 - 87 PatG Patent Transactions in the Life Sciences - A Global Guide to Agreements in the Sector, in: 1. Auflage Globe Law and Business, 2014 Handbuch des Fachanwalts Gewerblicher Rechtsschutz, in: 3. Auflage Heymanns, 2018 Mind the injunction gap - focus on unified patent court, in: Intellectual Property Magazine, 04/2014 A doctrine of equivalents in the UPC?, in: The Patent Lawyer, 2013 Second medical use or indication claims, in: GRUR Int 2014, p. 906 Relief in IP Proceedings other than injunction and damages, in: GRUR Int, 2013, p. 773 Überprotektion durch Geistiges Eigentum?, in: Nomos, 2009 |
会员资格和附属关系
| German Association of Industrial Property Law and Copyright Law (GRUR) Association of Experts of Industrial Property Law (VPP) International Association for the Protection of Intellectual Property (AIPPI) German Japanese Lawyer’s Association (DJJV) German Japanese Society (DJG) European Women’s Management Development International Network (EWMD) Women in IP e.V. |
语言
| English |
| French |
| Japanese |
最新新闻和观点
酒店与休闲
点击此处了解更多
6 things to watch in pharma and biotech patent litigation in 2023
2022年12月8日
Briefing
作者 Dr. Anja Lunze, LL.M. 以及 Dr. Nora E. Wessendorf, LL.M. (Washington)
UPC
点击此处了解更多
What is new on preliminary injunction proceedings in pharma and biotech cases in Germany – and would it be different under the UPC?
2022年9月14日
Briefing
